In the present study, we confirmed our previous results [8, 31] showing that renal cell carcinoma-derived CD105+ cells possess stem cell properties, such as clonogenicity, sphere formation ability, in vivo tumorigenic ability and endothelial cell differentiation capability. The gene discussed is ENG; the disease is renal cell carcinoma.